Butyrate as a differentiating agent: pharmacokinetics, analogues and current status
- 1 April 1994
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 78 (1-3) , 1-5
- https://doi.org/10.1016/0304-3835(94)90023-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Butyrate-induced reactivation of the fetal globin genes: A molecular treatment for theβ-hemoglobinophatiesCellular and Molecular Life Sciences, 1993
- Pharmacokinetic Studies of N-Butyric Acid Mono- and Polyesters Derived from MonosaccharidesJournal of Pharmaceutical Sciences, 1992
- Novel anticancer prodrugs of butyric acid. 2Journal of Medicinal Chemistry, 1992
- Derivatives of butyric acid as potential anti‐neoplastic agentsInternational Journal of Cancer, 1991
- Butyric monosaccharide ester‐induced cell differentiation and anti‐tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapyInternational Journal of Cancer, 1991
- New stable butyrate derivatives alter proliferation and differentiation in human mammary cellsInternational Journal of Cancer, 1991
- Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesisCancer Letters, 1990
- Short chain fatty acids in human large intestine, portal, hepatic and venous blood.Gut, 1987
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cellsCell, 1975